Hepatotoxizität nach Leberbestrahlung im Kindes- und Jugendalter: Ergebnisse des RiSK

Translated title of the contribution: Hepatotoxicity after liver irradiation in children and adolescents: Results from the RiSK

Pascal Rösler, Hans Christiansen, Rolf Dieter Kortmann, Carmen Martini, Christiane Matuschek, Frank Meyer, Christian Rübe, Thorsten Langer, Raphael Koch, Hans Theodor Eich, Normann Willich, Diana Steinmann*

*Corresponding author for this work
9 Citations (Scopus)


Aim: The aim of this study was to evaluate acute and late radiotherapy-associated hepatotoxicity in consideration of dose–volume effects and liver function in childhood and adolescence. Patients and methods: Since 2001, irradiated children and adolescents in Germany have been prospectively documented in the “Register of Treatment-Associated Late Effects After Radiotherapy of Malignant Diseases in Childhood and Adolescence (RiSK)” using standardized forms. Toxicity was graded according to the Radiation Therapy Oncology Group (RTOG) criteria. Results: Until April 2012, 1,392 children and adolescents from 62 radiotherapy centers were recruited. In all, 216 patients underwent irradiation of the liver (median age 9 years, range 1–18 years, 70 patients with total-body irradiation, TBI). For 75 % of patients without TBI, information on acute toxicity of the liver was available: 24 patients had acute toxicity of grade 1–4 (grade 1, 2, and 4, in 20, 3, and 1 patient, respectively), including five patients receiving simultaneous hepatotoxic chemotherapy. Information on late toxicity was documented in 465 forms from 216 patients, with a median follow-up of 2 years. A maximum grade of toxicity of ≥ 0 occurred in 18 patients over time (with grade 1, 2, and 3 toxicity occurring in 15, 2, and 1 patient, respectively), including three patients (17 %) with TBI. One of them received simultaneous hepatotoxic chemotherapy. In multivariable analysis, volume–dose correlations showed no statistically noticeable effect on acute or chronic toxicity. Conclusion: Only low hepatotoxicity developed in children after irradiation of various abdominal and thoracic tumors. Due to the low radiation doses to the liver (median liver dose = 5 Gy) and the low toxicities that were consecutively observed, dose–volume curves for liver toxicity could not be established. These findings reflect the cautious attitude of radiation oncologists in terms of attributable liver doses in the treatment of the investigated tumor entities. It offers the option of increasing these conservative doses if tumor control is necessary.

Translated title of the contributionHepatotoxicity after liver irradiation in children and adolescents: Results from the RiSK
Original languageGerman
JournalStrahlentherapie und Onkologie
Issue number5
Pages (from-to)413-420
Number of pages8
Publication statusPublished - 01.05.2015

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


Dive into the research topics of 'Hepatotoxicity after liver irradiation in children and adolescents: Results from the RiSK'. Together they form a unique fingerprint.

Cite this